Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68,500 JPY | -1.86% | -1.44% | +12.30% |
Apr. 12 | Invincible Investment Secures 1.7 Billion Yen to Repay Debt | MT |
Mar. 26 | Invincible Investment Acquires Casbee Certification for Two Properties | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the past twelve months, EPS forecast has been revised upwards.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
Ratings chart - Surperformance
Sector: Diversified REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.30% | 2.75B | - | ||
-13.27% | 11.96B | B | ||
-15.44% | 7.29B | A | ||
+1.44% | 5.49B | A | ||
-9.97% | 5.28B | A | ||
-10.56% | 5.16B | A- | ||
-0.31% | 4.52B | C+ | ||
-12.36% | 4.49B | C | ||
-4.85% | 4.39B | A- | ||
+4.01% | 3.91B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 8963 Stock
- Ratings Invincible Investment Corporation